Bugelski P J, Atif U, Molton S, Toeg I, Lord P G, Morgan D G
SmithKline Beecham Pharmaceuticals, The Frythe, Welwyn, Hertfordshire, United Kingdom.
Pharm Res. 2000 Oct;17(10):1265-72. doi: 10.1023/a:1026495503939.
Recent advances in combinatorial chemistry and high throughput screens for pharmacologic activity have created an increasing demand for in vitro high throughput screens for toxicological evaluation in the early phases of drug discovery.
To develop a strategy for such a screen, we have conducted a data mining study of the National Cancer Institute's Developmental Therapeutics Program (DTP) cytotoxicity database.
Using hierarchical cluster analysis, we confirmed that the different tissues of origin and individual cell lines showed differential sensitivity to compounds in the DTP Standard Agents database. Surprisingly, however, approaching the data globally, linear regression analysis showed that the differences were relatively minor. Comparison with the literature on acute toxicity in mice showed that the predictive power of growth inhibition was marginally superior to that of cell death.
This datamining study suggests that in designing a strategy for high throughput cytotoxicity screening: a single cell line, the choice of which may not be critical, can be used as a primary screen; a single end point may be an adequate measure and a cut off value for 50% growth inhibition between 10(-6) and 10(-8) M may be a reasonable starting point for accepting a cytotoxic compound for scale up and further study.
组合化学和药理活性高通量筛选技术的最新进展,使得在药物发现早期阶段对毒理学评估的体外高通量筛选需求日益增加。
为制定此类筛选策略,我们对美国国立癌症研究所的发展治疗项目(DTP)细胞毒性数据库进行了数据挖掘研究。
使用层次聚类分析,我们证实了不同来源组织和单个细胞系对DTP标准药物数据库中的化合物表现出不同的敏感性。然而,令人惊讶的是,从整体数据来看,线性回归分析表明差异相对较小。与小鼠急性毒性文献的比较表明,生长抑制的预测能力略优于细胞死亡。
这项数据挖掘研究表明,在设计高通量细胞毒性筛选策略时:可选用单一细胞系作为初筛,其选择可能并不关键;单一终点可能就足够,对于细胞毒性化合物,10(-6)至10(-8) M之间50%生长抑制的截断值可能是接受其进行放大和进一步研究的合理起点。